The store will not work correctly when cookies are disabled.
9-Methoxy-4-methyl-2,3,4,5,6,10b-hexahydro-1H-pyrrolo[2,1-a]isoquinolin-4-ium iodide
ID: ALA4082570
PubChem CID: 137647685
Max Phase: Preclinical
Molecular Formula: C14H20INO
Molecular Weight: 218.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2c(c1)C1CCC[N+]1(C)CC2.[I-]
Standard InChI: InChI=1S/C14H20NO.HI/c1-15-8-3-4-14(15)13-10-12(16-2)6-5-11(13)7-9-15;/h5-6,10,14H,3-4,7-9H2,1-2H3;1H/q+1;/p-1
Standard InChI Key: MHQFIPMPNASAIS-UHFFFAOYSA-M
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
38.9858 -28.2055 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
39.6913 -30.3461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4051 -29.9325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4022 -29.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6895 -28.7004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9832 -29.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9873 -29.1138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5666 -29.9259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2751 -30.3434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5706 -29.1067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.2801 -28.7067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1135 -27.9080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3076 -27.8129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9681 -28.5554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1125 -28.6944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.8259 -29.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8562 -29.5138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 7 1 0
6 7 2 0
6 9 1 0
7 11 1 0
10 8 1 0
8 9 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 10 1 0
4 15 1 0
15 16 1 0
10 17 1 0
M CHG 2 1 -1 10 1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 218.32 | Molecular Weight (Monoisotopic): 218.1539 | AlogP: 2.53 | #Rotatable Bonds: 1 |
Polar Surface Area: 9.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: -1.90 | CX LogD: -1.90 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.66 | Np Likeness Score: 1.15 |
References
1. Crestey F, Jensen AA, Soerensen C, Magnus CB, Andreasen JT, Peters GHJ, Kristensen JL.. (2018) Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts., 61 (4): [PMID:29384668] [10.1021/acs.jmedchem.7b01895] |